Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

85.00p
   
  • Change Today:
      2.15p
  • 52 Week High: 171.20
  • 52 Week Low: 67.00
  • Currency: UK Pounds
  • Shares Issued: 961.94m
  • Volume: 2,402,237
  • Market Cap: £817.65m

Dr Martens treads close to FTSE 100 as reshuffle looms

By Sean Farrell

Date: Wednesday 17 Feb 2021

LONDON (ShareCast) - (Sharecast News) - Dr Martens could boot its way straight into the FTSE 100 after the footwear brand's shares surged following its successful flotation.
Shares of Dr Martens have leapt by a third since the company's initial public offer in late January, valuing the group at about £5bn. It is one of a series of recent IPOs that also included FTSE 250 candidates Moonpig and Bytes Technology.

Dr Martens is in the running to replace Pennon, the owner of South West Water, when the quarterly FTSE 100 reshuffle is announced on 3 March. Dr Martens is vying with engineering group Weir, whose market value is £5.1bn, to displace Pennon, which is valued at £3.9bn.

If Dr Martens doesn't break into the index of top shares it appears to have assured itself a place in the FTSE 250 list of midsized corporates. If so, it is likely to be joined by Moonpig, the online greetings company, and Bytes, the cloud storage and security group, which also had successful flotations in the past two months.

Dr Martens has come a long way from its roots in the 1960s as a privately owned business selling comfort footwear designed by its eponymous German founder. The air-cushioned boots and shoes were adopted by skinheads and a succession of youth cults including punks, rude boys and grunge to become an edgy UK fashion brand.

The business was owned by the Griggs family, which licensed the design in 1960, until 2013 when they sold to private equity firm Permira for £300m and kept a 10% stake. The company's IPO received strong demand but its fortunes have waxed and waned with trends while outside the spotlight of the public market.

Susannah Streeter, an investment analyst at Hargreaves Lansdown, said: "The bootmaker made famous for dressing subversive types has gone full City style with a successful IPO, a buoyant share price and a market capitalisation of £5bn.

"It may now be basking in the style spotlight but fashion is fickle and that could reflect in its share price down the line. Widening its footprint of styles is likely to be the path trodden in the future, but that also risks diluting the core brand."

Weir is in contention to rejoin the FTSE 100 after selling its oil and gas division to Caterpillar in October and switching its focus to mining. Its shares have roughly tripled in value since March 2020 compared with a 40% rise in the FTSE 250 as investors have bet on a mining revival.

Pennon is sitting a big pile of cash after selling its waste management business in 2020 but has not offered shareholders much to be enthusiastic about. Moonpig and Bytes have got investors excited over the shift to online shopping and working wrought by the Covid-19 crisis.

Streeter said: "Three newly listed star players are leading contenders to land coveted FTSE positions. Dr Martens is set to stomp into the FTSE 250 but has an has outside chance of taking the next step into the FTSE 100. Tech newcomers Moonpig and The Bytes Group have also floated into potential FTSE 250 territory."

The FTSE 100 reshuffle is managed so that companies do not move in and out too often. To be relegated a company's market value must be below that of the top 10 companies beneath it and to gain promotion a FTSE 250 company's valuation must exceed that of the bottom 10 in the FTSE 100.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 85.00p
Change Today 2.15p
% Change 2.60 %
52 Week High 171.20
52 Week Low 67.00
Volume 2,402,237
Shares Issued 961.94m
Market Cap £817.65m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.01% above the market average57.01% above the market average57.01% above the market average57.01% above the market average57.01% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Price Trend
76.95% below the market average76.95% below the market average76.95% below the market average76.95% below the market average76.95% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Income
63.93% above the market average63.93% above the market average63.93% above the market average63.93% above the market average63.93% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
2.71% below the market average2.71% below the market average2.71% below the market average2.71% below the market average2.71% below the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 04-Jan-24 08-Jun-23
Paid 02-Feb-24 18-Jul-23
Amount 1.56p 4.28p

Trades for 17-May-2024

Time Volume / Share Price
16:51 2,727 @ 85.00p
16:35 10,000 @ 84.50p
16:35 10,000 @ 84.50p
16:35 116,578 @ 85.00p
16:35 458,801 @ 85.00p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson

Top of Page